Growth Metrics

OptimizeRx (OPRX) Other Non-Current Assets: 2010-2025

Historic Other Non-Current Assets for OptimizeRx (OPRX) over the last 16 years, with Q3 2025 value amounting to $113.9 million.

  • OptimizeRx's Other Non-Current Assets rose 3135911.6% to $113.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $113.9 million, marking a year-over-year increase of 3135911.6%. This contributed to the annual value of $117.0 million for FY2024, which is 919.13% down from last year.
  • As of Q3 2025, OptimizeRx's Other Non-Current Assets stood at $113.9 million, which was up 3135911.6% from $115.1 million recorded in Q2 2025.
  • OptimizeRx's 5-year Other Non-Current Assets high stood at $128.9 million for Q4 2023, and its period low was $362000.0 during Q3 2024.
  • For the 5-year period, OptimizeRx's Other Non-Current Assets averaged around $55.2 million, with its median value being $36.1 million (2023).
  • As far as peak fluctuations go, OptimizeRx's Other Non-Current Assets tumbled by 9900.52% in 2024, and later soared by 3135911.6% in 2025.
  • Over the past 5 years, OptimizeRx's Other Non-Current Assets (Quarter) stood at $25.7 million in 2021, then skyrocketed by 39.68% to $35.9 million in 2022, then soared by 258.67% to $128.9 million in 2023, then fell by 9.19% to $117.0 million in 2024, then fell by 2.7% to $113.9 million in 2025.
  • Its Other Non-Current Assets was $113.9 million in Q3 2025, compared to $115.1 million in Q2 2025 and $115.9 million in Q1 2025.